Literature DB >> 22441983

LNK (SH2B3) is a key regulator of integrin signaling in endothelial cells and targets α-parvin to control cell adhesion and migration.

Julie Devallière1, Mathias Chatelais, Juliette Fitau, Nathalie Gérard, Philippe Hulin, Laura Velazquez, Christopher E Turner, Béatrice Charreau.   

Abstract

Focal adhesion (FA) formation and disassembly play an essential role in adherence and migration of endothelial cells. These processes are highly regulated and involve various signaling molecules that are not yet completely identified. Lnk [Src homology 2-B3 (SH2B3)] belongs to a family of SH2-containing proteins with important adaptor functions. In this study, we showed that Lnk distribution follows that of vinculin, localizing Lnk in FAs. Inhibition of Lnk by RNA interference resulted in decreased spreading, whereas sustained expression dramatically increases the number of focal and cell-matrix adhesions. We demonstrated that Lnk expression impairs FA turnover and cell migration and regulates β1-integrin-mediated signaling via Akt and GSK3β phosphorylation. Moreover, the α-parvin protein was identified as one of the molecular targets of Lnk responsible for impaired FA dynamics and cell migration. Finally, we established the ILK protein as a new molecular partner for Lnk and proposed a model in which Lnk regulates α-parvin expression through its interaction with ILK. Collectively, our results underline the adaptor Lnk as a novel and effective key regulator of integrin-mediated signaling controlling endothelial cell adhesion and migration.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22441983      PMCID: PMC3360145          DOI: 10.1096/fj.11-193383

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  63 in total

1.  Force-dependent integrin-cytoskeleton linkage formation requires downregulation of focal complex dynamics by Shp2.

Authors:  Götz von Wichert; Beatrice Haimovich; Gen-Sheng Feng; Michael P Sheetz
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

Review 2.  Paxillin: adapting to change.

Authors:  Michael C Brown; Christopher E Turner
Journal:  Physiol Rev       Date:  2004-10       Impact factor: 37.312

3.  Increased numbers of B-1 cells and enhanced responses against TI-2 antigen in mice lacking APS, an adaptor molecule containing PH and SH2 domains.

Authors:  Masanori Iseki; Chiyomi Kubo; Sang-Mo Kwon; Akiko Yamaguchi; Yuki Kataoka; Nobuaki Yoshida; Kiyoshi Takatsu; Satoshi Takaki
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

4.  The pseudoactive site of ILK is essential for its binding to alpha-Parvin and localization to focal adhesions.

Authors:  Koichi Fukuda; Sudhiranjan Gupta; Ka Chen; Chuanyue Wu; Jun Qin
Journal:  Mol Cell       Date:  2009-12-11       Impact factor: 17.970

5.  Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.

Authors:  Wei Tong; Harvey F Lodish
Journal:  J Exp Med       Date:  2004-08-30       Impact factor: 14.307

6.  RhoA activation mediates phosphatidylinositol 3-kinase-dependent proliferation of human vascular endothelial cells: an alloimmune mechanism of chronic allograft nephropathy.

Authors:  Stéphanie Coupel; Fabrice Leboeuf; Gwénola Boulday; Jean-Paul Soulillou; Béatrice Charreau
Journal:  J Am Soc Nephrol       Date:  2004-09       Impact factor: 10.121

7.  Roles of a conserved family of adaptor proteins, Lnk, SH2-B, and APS, for mast cell development, growth, and functions: APS-deficiency causes augmented degranulation and reduced actin assembly.

Authors:  Chiyomi Kubo-Akashi; Masanori Iseki; Sang-Mo Kwon; Hitoshi Takizawa; Kiyoshi Takatsu; Satoshi Takaki
Journal:  Biochem Biophys Res Commun       Date:  2004-03-05       Impact factor: 3.575

8.  Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice.

Authors:  D Ilić; Y Furuta; S Kanazawa; N Takeda; K Sobue; N Nakatsuji; S Nomura; J Fujimoto; M Okada; T Yamamoto
Journal:  Nature       Date:  1995-10-12       Impact factor: 49.962

9.  Regulation of the VLA integrin-ligand interactions through the beta 1 subunit.

Authors:  A G Arroyo; P Sánchez-Mateos; M R Campanero; I Martín-Padura; E Dejana; F Sánchez-Madrid
Journal:  J Cell Biol       Date:  1992-05       Impact factor: 10.539

10.  Phosphorylation of actopaxin regulates cell spreading and migration.

Authors:  Dominic M Clarke; Michael C Brown; David P LaLonde; Christopher E Turner
Journal:  J Cell Biol       Date:  2004-09-07       Impact factor: 10.539

View more
  19 in total

Review 1.  The genetic basis of peripheral arterial disease: current knowledge, challenges, and future directions.

Authors:  Iftikhar J Kullo; Nicholas J Leeper
Journal:  Circ Res       Date:  2015-04-24       Impact factor: 17.367

Review 2.  Meta-analyses of four eosinophil related gene variants in coronary heart disease.

Authors:  Jiangfang Lian; Yi Huang; R Stephanie Huang; Limin Xu; Yanping Le; Xi Yang; Weifeng Xu; Xiaoyan Huang; Meng Ye; Jianqing Zhou; Shiwei Duan
Journal:  J Thromb Thrombolysis       Date:  2013-11       Impact factor: 2.300

Review 3.  Peripheral Arterial Disease Genetics: Progress to Date and Challenges Ahead.

Authors:  Nathan Belkin; Scott M Damrauer
Journal:  Curr Cardiol Rep       Date:  2017-11-01       Impact factor: 2.931

4.  PEDF expression regulates the proangiogenic and proinflammatory phenotype of the lung endothelium.

Authors:  Eui Seok Shin; Christine M Sorenson; Nader Sheibani
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-12-06       Impact factor: 5.464

5.  Targeted Sequencing Study to Uncover Shared Genetic Susceptibility Between Peripheral Artery Disease and Coronary Heart Disease-Brief Report.

Authors:  Maya S Safarova; Xiao Fan; Erin E Austin; Natalie van Zuydam; Jemma Hopewell; Daniel J Schaid; Iftikhar J Kullo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-06       Impact factor: 8.311

Review 6.  ILK: a pseudokinase in the center stage of cell-matrix adhesion and signaling.

Authors:  Jun Qin; Chuanyue Wu
Journal:  Curr Opin Cell Biol       Date:  2012-07-02       Impact factor: 8.382

7.  Overlap between common genetic polymorphisms underpinning kidney traits and cardiovascular disease phenotypes: the CKDGen consortium.

Authors:  Matthias Olden; Alexander Teumer; Murielle Bochud; Cristian Pattaro; Anna Köttgen; Stephen T Turner; Rainer Rettig; Ming-Huei Chen; Abbas Dehghan; Francois Bastardot; Reinhold Schmidt; Peter Vollenweider; Heribert Schunkert; Muredach P Reilly; Myriam Fornage; Lenore J Launer; Germaine C Verwoert; Gary F Mitchell; Joshua C Bis; Christopher J O'Donnell; Ching-Yu Cheng; Xueling Sim; David S Siscovick; Josef Coresh; W H Linda Kao; Caroline S Fox; Conall M O'Seaghdha
Journal:  Am J Kidney Dis       Date:  2013-03-06       Impact factor: 8.860

8.  Advantages of Papio anubis for preclinical testing of immunotoxicity of candidate therapeutic antagonist antibodies targeting CD28.

Authors:  Nicolas Poirier; Caroline Mary; Stephanie Le Bas-Bernardet; Veronique Daguin; Lyssia Belarif; Melanie Chevalier; Jeremy Hervouet; David Minault; Simon Ville; Vianney Charpy; Gilles Blancho; Bernard Vanhove
Journal:  MAbs       Date:  2014-03-05       Impact factor: 5.857

9.  Bortezomib, C1-inhibitor and plasma exchange do not prolong the survival of multi-transgenic GalT-KO pig kidney xenografts in baboons.

Authors:  S Le Bas-Bernardet; X Tillou; J Branchereau; N Dilek; N Poirier; M Châtelais; B Charreau; D Minault; J Hervouet; K Renaudin; C Crossan; L Scobie; Y Takeuchi; M Diswall; M E Breimer; N Klar; M R Daha; P Simioni; S C Robson; M B Nottle; E J Salvaris; P J Cowan; A J F d'Apice; D H Sachs; K Yamada; I Lagutina; R Duchi; A Perota; G Lazzari; C Galli; E Cozzi; J-P Soulillou; B Vanhove; G Blancho
Journal:  Am J Transplant       Date:  2015-02       Impact factor: 8.086

10.  β1 integrin signaling maintains human epithelial progenitor cell survival in situ and controls proliferation, apoptosis and migration of their progeny.

Authors:  Nancy Ernst; Arzu Yay; Tamás Bíró; Stephan Tiede; Martin Humphries; Ralf Paus; Jennifer E Kloepper
Journal:  PLoS One       Date:  2013-12-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.